Vicor Corp SEC Filings

Vicor (VICR) posted a sharp turnaround for Q2 2025. Total revenue plus a $45 m patent-litigation settlement reached $141.0 m; product+royalty revenue alone rose 11.9 % YoY to $96.0 m. Gross margin expanded to 65.3 % (47.1 % ex-settlement) and operating income jumped to $45.4 m from $0.2 m. Net income swung to $41.2 m ($0.91 diluted EPS) versus a $1.2 m loss in Q2 2024.

Growth was led by Advanced Products. Advanced revenue climbed 30.6 % to $60.6 m, while Brick Products fell 10.1 % to $35.5 m. Asia-Pacific sales surged 44 % and now represent 40 % of quarterly revenue; U.S. sales declined 5 %. Royalty income improved 11.6 % to $10.4 m.

Balance-sheet strength improved. Cash & equivalents increased $61 m Q-to-Q to $338.5 m, supported by $85.4 m operating cash flow and the settlement. Inventories fell 10 % YTD, while share repurchases totaled $17.6 m. The company remains debt-free but carries a $27.6 m litigation accrual tied to the SynQor patent case, with post-judgment interest still accruing. Backlog slipped 10 % sequentially to $155.2 m, hinting at potential near-term demand moderation.

Vicor Corp (VICR) – SEC Form 4 filing dated 07/10/2025

Philip D. Davies, the company’s Vice President of Global Sales & Marketing and a Director, reported a grant of 20,000 non-qualified stock options on 07/09/2025. The options carry an exercise price of $46.72, expire on 07/09/2035, and vest over a five-year period under Vicor’s Amended & Restated 2000 Stock Option and Incentive Plan. No common shares were bought or sold in the open market.

After this award, Davies’ direct holdings stand at 15,763 shares of common stock and 20,000 derivative securities (options). The filing reflects routine executive compensation and does not disclose any other material transactions.

Vicor Corporation (NASDAQ: VICR) filed a Form 8-K reporting the voting results of its 20 June 2025 Annual Meeting (Item 5.07).

Shareholders considered one proposal: set the Board size at 11 and elect the entire slate of 11 directors to serve until the 2026 meeting. Support was strong; each nominee received between 127.2 million and 131.9 million votes FOR, while withheld votes ranged from 3.97 million to 8.69 million. No broker non-votes or abstentions were recorded.

Vicor’s dual-class structure remains in place—each Common share equals one vote, each Class B share equals ten votes—reinforcing the existing voting power dynamics.

The filing contains no financial metrics, transactions, or other material events beyond routine governance matters.

Vicor Corp (VICR) – Form 4 insider filing dated 06/23/2025

Director John Zheng Shen received a grant of 4,539 non-qualified stock options on 06/20/2025 under the company’s Amended & Restated 2000 Stock Option and Incentive Plan. The options carry an exercise price of $44.07 per share and expire on 06/20/2035. No shares were bought or sold in the open market; the transaction strictly reflects a compensation-related award. Following the grant, Shen beneficially owns 4,539 derivative securities linked to common stock, held directly.

The filing is routine and does not disclose any immediate cash transactions, changes in ownership percentage, or broader strategic implications for Vicor’s capital structure.

Vicor Corp (VICR) – Form 4 insider filing dated 06/23/2025 discloses that Claudio Tuozzolo, a Corporate Vice President and Director, received a grant of 4,539 non-qualified stock options on 06/20/2025 under the company’s Amended & Restated 2000 Stock Option and Incentive Plan. The options have an exercise price of $44.07, a 10-year term expiring 06/20/2035, and will vest over five years (standard 20 % per-year schedule implied by plan language). No cash consideration was paid for the grant (price $0).

No shares of common stock were acquired or disposed of in Table I; Tuozzolo’s direct beneficial ownership remains 33,622 shares following the transaction. After the option grant, he also directly holds 4,539 derivative securities. The filing includes the customary signature by attorney-in-fact on 06/23/2025 and contains no indications of a Rule 10b5-1 trading plan or any sales activity.

From an investor perspective, the filing represents routine equity-based compensation aimed at aligning executive incentives with shareholder interests. It does not alter Vicor’s capital structure, cash flow, or immediate financial outlook. The relatively modest size of the option grant (≈0.01 % of the 43 million shares outstanding) suggests minimal dilution risk and limited market impact.

Vicor Corporation (VICR) – Form 4 insider transaction summary

On 06/20/2025, director Andrew D’Amico received a non-qualified stock option for 4,539 common shares of Vicor. The option’s exercise price is $44.07—generally the market price at the grant date—and it will expire on 06/20/2035. According to the footnote, the grant was made under the company’s Amended and Restated 2000 Stock Option and Incentive Plan and will vest ratably over five years. No shares were purchased or sold outright; the filing only records the derivative security grant. Following the transaction, D’Amico beneficially owns 4,539 derivative securities (options) and no change to any direct common-stock position is disclosed.

This type of grant is a routine component of director compensation. It modestly aligns the director’s interests with shareholders by linking potential value to future share-price performance, but the size of the grant—4,539 shares, roughly US$0.2 million based on the strike price—is small relative to Vicor’s market capitalization and average daily trading volume. There are no cash proceeds to Vicor and no immediate dilution because the options are unexercised. Investors should consider it an ordinary governance event rather than a signal of near-term fundamental change.